Clinical Trial Update: Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer

View source ↗

Summary

This document notes that a clinical trial evaluating treatment for ESR1-mutated HR+/HER2- advanced breast cancer in Chinese patients is currently recruiting, sp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Snippet

Sponsor: SciClone Pharmaceuticals | Conditions: ESR1 Gene Mutation, Advanced Breast Cancer | Status: RECRUITING